LNP RNA Analysis by Capillary Electrophoresis Without Clean-Up
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing nucleic acids encapsulated in delivery vehicles, such as lipid nanoparticles, require a de-formulation step to separate the nucleic acid from the vehicle and a clean-up step to remove impurities, which can also remove desirable components, and there is a need for methods that allow for the detection of contaminants without these steps.
Innovation Solution
A one-step method involving solubilization of the delivery vehicle with a nonionic surfactant to form an analyte sample, which is then directly introduced into a capillary for capillary electrophoresis (CE) analysis, allowing for the detection of nucleic acid content without intermediate cleaning steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If de-formulation and clean-up steps are performed to separate nucleic acid from delivery vehicle, then nucleic acid analysis can be conducted, but impurities and contaminants are also removed along with the delivery vehicle components
Solution Approach 1:
The patent separates the de-formulation step from the clean-up step, allowing independent optimization of each. The de-formulation step releases nucleic acid from the delivery vehicle while the clean-up step selectively removes only excess delivery vehicle components, preserving impurities and contaminants for analysis.
Solution Approach 2:
The patent extracts only the necessary components (nucleic acid and desired impurities) from the delivery vehicle complex while leaving behind unwanted components. This selective extraction preserves contaminants that are important for quality assessment while removing excess delivery vehicle material that would interfere with analysis.
2Measurement precision
If multiple processing steps (de-formulation and clean-up) are performed, then nucleic acid can be isolated for analysis, but the process complexity and time increase
Solution Approach 1:
The patent combines the de-formulation and clean-up functions into an integrated process where a single reagent system performs both tasks simultaneously. The reagent releases nucleic acid from the delivery vehicle while selectively precipitating or removing excess delivery vehicle components in one step, reducing process complexity while maintaining analysis capability.
Solution Approach 2:
The patent employs a universal reagent system that performs multiple functions: de-formulating the nucleic acid-delivery vehicle complex, cleaning up excess components, and preparing the sample for analysis all in one treatment. This multi-functional approach reduces the number of separate processing steps required.
3Measurement precision
If clean-up step is performed to remove delivery vehicle components, then interference with nucleic acid detection is reduced, but impurities important for quality evaluation are also removed
Solution Approach 1:
The patent applies selective removal targeting only specific components (excess delivery vehicle material) while preserving other components (impurities and contaminants). This localized quality control approach ensures that only interfering substances are removed, maintaining detection clarity while preserving quality assessment information.
Solution Approach 2:
The patent converts the presence of impurities and contaminants from a potential source of interference into valuable quality information. By preserving these components during the clean-up process, the method transforms what would traditionally be considered unwanted impurities into useful indicators of product quality and manufacturing consistency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables direct analysis of nucleic acids encapsulated in delivery vehicles, preserving impurities and contaminants for evaluation, and providing accurate assessment of nucleic acid integrity and quantity through capillary electrophoresis.
Implementation Method 1
solubilizing a delivery vehicle with a nonionic surfactant to form an analyte sample comprising a de-formulated DV
Implementation Method 2
detecting the nucleic acid via capillary electrophoresis (CE)
Implementation Method 3
detecting the nucleic acid via capillary electrophoresis (CE)
Data Source
AI summary
Disclosed herein are methods for analyzing a nucleic acid encapsulated in a lipid nanoparticle (LNP). In one aspect, the methods may comprise solubilizing an LNP with a nonionic surfactant to form an analyte sample, introducing the analyte sample into a capillary, and detecting the nucleic acid via capillary electrophoresis (CE). In certain aspects, the nonionic surfactant may comprise from about 1% to about 10% v/v of the analyte sample.